IGF1 Signaling Regulates Neuropeptide Expression in Hypothalamic Neurons Under Physiological and Pathological Conditions
Endocrinology · 2025
DOI: 10.1210/endocr/bqaf051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2025. Verfasst von Wenyuan He und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Toronto, Toronto, ON, Canada M5S 1A8. Hauptthemen laut MEDLINE: Hypothalamus, Insulin-Like Growth Factor I, Neurons, Neuropeptides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSERC, Canada Foundation for Innovation, Canada Research Chairs.
Abstract (Originalsprache)
Insulin-like growth factor 1 (IGF1) plays a critical role in metabolism and aging, but its role in the brain remains unclear. This study examined whether hypothalamic neurons respond to IGF1 and how its actions are modulated. RT-qPCR and single-cell RNA sequencing indicated that Igf1r mRNA is expressed in neuropeptide Y/Agouti-related peptide (NPY/AgRP) neurons but has higher expression in pro-opiomelanocortin (POMC) neurons. IGF1 binding proteins Igfbp3 and Igfbp5 were significantly expressed, whereby Igfbp5 levels were modulated by fasting, nutrient availability, and circadian rhythms, implying that IGF1 signaling can be controlled by multiple mechanisms. In mouse and human models, IGF1 regulated Agrp, Npy, Pomc, Cartpt, Spx, Gal, and Fam237b expression, producing an overall anorexigenic profile. Hyperinsulinemia induced IGF1 resistance, accompanied by reduced IGF1R protein, as well as Igf1r and Irs2 mRNA expression via over-activation of phosphoinositide 3-kinase/forkhead box O1 (PI3K-FOXO1) signaling. Thus, hypothalamic neurons respond to IGF1 under physiological conditions, and hyperinsulinemia is a novel mechanism that drives cellular IGF1 resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, University of Toronto, Toronto, ON, Canada M5S 1A8.
- Department of Medicine, University of Toronto, Toronto, ON, Canada M5S 1A8.
- Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON, Canada M5S 1A8.
ORCID-Profile: Denise D Belsham
Förderung
- NSERC
- Canada Foundation for Innovation
- Canada Research Chairs
- CGS
Zitieren
APA
He, W., Loganathan, N., & Belsham, D. D. (2025). IGF1 Signaling Regulates Neuropeptide Expression in Hypothalamic Neurons Under Physiological and Pathological Conditions. Endocrinology. https://doi.org/10.1210/endocr/bqaf051
Vancouver
He W, Loganathan N, Belsham DD. IGF1 Signaling Regulates Neuropeptide Expression in Hypothalamic Neurons Under Physiological and Pathological Conditions. Endocrinology. 2025. doi:10.1210/endocr/bqaf051
BibTeX
@article{He2025,
author = {He, Wenyuan and Loganathan, Neruja and Belsham, Denise D},
title = {IGF1 Signaling Regulates Neuropeptide Expression in Hypothalamic Neurons Under Physiological and Pathological Conditions},
journal = {Endocrinology},
year = {2025},
doi = {10.1210/endocr/bqaf051}
}
EUVIMED